Ocrelizumab trials for Multiple sclerosis

All Ocrelizumab trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying Ocrelizumab for Multiple sclerosis

• A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
  NCT07321093 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
  NCT07282574 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 108 locations
• A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
  NCT06780150 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 92 locations
• An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
  NCT06675955 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 44 locations
• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
  NCT06846281 · Phase: Phase 3 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 129 locations
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 13 locations
• Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
  NCT07389590 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Ocrelizumab for Multiple sclerosis?

7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.